Dr Louise Wood, Director of Science, Research & Evidence, has released a letter to provide clarity on the prioritised status of early phase COVID-19 trials.
Author: NJRO
Leading the COVID Challenge from the front lines
BLOG: Tony De Soyza describes the NUTH COVID-19 research strategy
Recruiting Patients to Clinical Trials for COVID-19 Therapeutics
A request for help in recruitment to COVID-19 studies has been sent by the Chief Medical Officers and National Medical Director.
Adaptive COVID-19 Treatment Trial (ACTT) insights with Dr Ashley Price
BLOG: An international trial which recruited patients in NuTH shows improved recovery rate
Lancet Report
The safety of our staff during the COVID-19 pandemic has always been paramount and we’re proud that in Newcastle, we have been a leader in staff testing from the very beginning of this crisis.
COV-HI project investigates hyper-inflammation in COVID-19
The Newcastle Joint Research Office (NJRO) has been involved in the conception of a UK-wide database to provide rapid reporting on the incidence of hyper-inflammation in COVID-19 and the association with adverse outcome and potential to be modulated by intervention with biologic therapy. The database provides a rapid means of collating information from multiple sites.